Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vera Therapeutics, Inc. | Chief Development Officer | Stock Option (right to buy) | 275K | Jan 5, 2024 | Direct | ||
Sierra Oncology, Inc. | Chief Reg & Tech Ops Officer | Stock Option (right to buy) | 0 | Jul 1, 2022 | Direct | ||
Vera Therapeutics, Inc. | Chief Development Officer | No securities beneficially owned | 0 | Jan 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VERA | Vera Therapeutics, Inc. | Jan 5, 2024 | 1 | $0 | 4 | Jan 9, 2024 | Chief Development Officer |
VERA | Vera Therapeutics, Inc. | Jan 5, 2024 | 0 | $0 | 3 | Jan 9, 2024 | Chief Development Officer |
SRRA | Sierra Oncology, Inc. | Jul 1, 2022 | 4 | $0 | 4 | Jul 1, 2022 | Chief Reg & Tech Ops Officer |
SRRA | Sierra Oncology, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Chief Reg & Tech Ops Officer |
SRRA | Sierra Oncology, Inc. | Apr 5, 2022 | 6 | -$162K | 4 | Apr 7, 2022 | Chief Reg & Tech Ops Officer |
SRRA | Sierra Oncology, Inc. | Mar 18, 2022 | 3 | -$2.5K | 4 | Mar 22, 2022 | Chief Reg & Tech Ops Officer |
SRRA | Sierra Oncology, Inc. | Mar 17, 2022 | 3 | -$86.3K | 4 | Mar 17, 2022 | Chief Reg & Tech Ops Officer |
SRRA | Sierra Oncology, Inc. | Mar 14, 2022 | 1 | $0 | 4 | Mar 14, 2022 | Chief Reg & Tech Ops Officer |
SRRA | Sierra Oncology, Inc. | Feb 7, 2022 | 3 | -$203K | 4 | Feb 8, 2022 | Chief Reg & Tech Ops Officer |
SRRA | Sierra Oncology, Inc. | Jan 26, 2022 | 4 | -$75K | 4 | Jan 28, 2022 | Chief Reg & Tech Ops Officer |